ARTICLE | Clinical News
ADXS-HPV: Additional Phase II data
November 12, 2012 8:00 AM UTC
Updated preliminary data from an Indian Phase II trial in 110 women with recurrent or refractory cervical cancer showed that IV ADXS-HPV with or without cisplatin produced 6 complete responses, 6 part...